Dr Jay Naik

Medical oncology


  • Fee assured

This healthcare professional let us know that they are currently available for:

    • Phone consultations
    • Video consultations

Last updated: 12 Nov 2020

Specialises in

  • Breast


  • Home chemotherapy

About me

I am a Consultant Medical Oncologist specializing in cancer diagnosis, medical treatment, and follow-up for women (and men) with breast cancer, with an emphasis in helping patients to understand their disease and rationale for treatment, resulting in the best decision for that person in their given situation. I practise at Spire Roundhay Hospital and from February 2020, Harrogate Hospital. I have expertise in treating patients with newly diagnosed early breast cancer either before or after surgery, and in those people where cancer returns some time after previous treatments.

Modern treatment for cancer requires the careful integration of diagnostic procedures, surgical treatment, medical therapies with chemotherapy, biological or endocrine therapy, and radiotherapy. This is brought about through a multidisciplinary team approach where pathologists, radiologists, oncologists, surgeons, and specialist nurses meet on a regular basis to consider the diagnosis and best treatment for each patient. I am imminently taking on a new challenge becoming a member of the multidisciplinary team for breast cancer at Harrogate and District Foundation Trust, working at Harrogate Hospital.

Modern cancer therapies increasingly exploit knowledge of the nature of each individual tumour. Treatments have advanced remarkably in recent years by identifying specific changes present in cancer cells for which targeting drugs are known.

More specific choices for treatment consequently are found, with better chances of success. As such I am familiar in the analysis of the individual tumour of patients, with several standard tests applied to refine treatment choices for breast cancers and, where appropriate, special tests to guide treatment using technologies such as Oncotype DX.

I have several years of experience treating breast cancer (in men as well as in women) using chemotherapy, hormonal and biological therapy (e.g , trastuzumab (Herceptin) pertuzumab (Perjeta), trastuzumab emtansine (Kadcyla) and everolimus (Afinitor)). I also have extensive experience in supportive therapies such as bisphosphonates and RANK-ligand inhibitors (e.g. Denosumab).

Above all I value strongly doing my utmost to support you through what can be a bewildering array of considerations and options and the most testing experience you may face. I aim to relate information in an understandable way, placing an emphasis on understanding the individual needs and preferences that make you who are.

This approach has been validated by my NHS patients who nominated me and my team for Mid Yorkshire's 'Kate Granger Compassionate Care Award'. We were shortlisted and subsequently won being presented with the award in May 2018.

Areas of interest

Breast Cancer;

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0003

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (5-50)

    Spire Leeds Hospital (5-50)

  • X0004

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (5-50)

    Spire Leeds Hospital (5-50)

  • AA843

    Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-21 days - (5-50)

  • AA844

    Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-28 days - (5-50)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.